BCR and COVID-19: Since protein kinase in integral in the signaling process of mineralocorticoid receptors both on and within the nucleus of endothelial cells [100], it can be hypothesized that COVID-19 provokes resistant hypertensive tendencies partially by manipulating the expression of BCR-ABL in the mineralocorticoid receptor pathway, decreasing the activity of tyrosine kinase [100].